Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1646-1650

  Barnes, C J ^a   Lee, M ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Aspirin; Carcinogenesis; Chemoprevention; Colon; Rat

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETYLSALICYLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CANCER INCIDENCE; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

EID: 0033041892     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690263     Document Type: Article

References (32)

1. Abramson S, Korchak H, Ludewig R, Edelson H, Haines K, Levin RI, Herman R, Rider L, Kimmel S and Weissman G (1985) Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 82: 7227-7231
2. Min mouse model with aspirin. Gastroenterology 114: 873-877
3. Barnes CJ, Lee M, Hardman WE and Cameron IL (1995) Aspirin, age, and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic crypts. Cell Prolif 28: 59-71
4. Barnes CJ, Hardman WE, Cameron IL and Lee M (1997) Aspirin, but not sodium salicylate, indomethacin, or nabumelone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats. Dig Dis Sci 42: 920-926
5. Barnes CJ, Gauntt SA, Henderson LA, Yang Y, Ulmer RJ, Puleo-Scheppke BA, Stothoff AF, Hardman WE, Cameron IL and Lee M (1998a) Long term aspirin administration, but not intermittent dosing, is required to suppress colon tumorigenesis in rats. Toxicol Sci (suppl.) 42: 319
6. Barnes CJ, Cameron IL, Hardman WE and Lee M (1998b) NSAID modulation of colonic epithelial cell proliferation and apoptosis at intermediate biomarkers of induced rat colon cancer. Br J Cancer 77: 573-580
7. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, Decosse JJ and Bertagnolli MM. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56: 2556-2560
8. Cameron IL, Ord VA, Hunter KE and Heitman DW (1990) Colon carcinogenesis: modulation of progression. In Colon Cancer Cells, Moyer MP and Poste G (eds), pp. 63-84. Academic Press: Orlando
9. Chiu C-C, Mcentee MF, and Whelan J (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res 57: 4267-4273
10. Craven PA and Derubertis FR (1992) Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 13: 541-546
11. Dubois RN, Radhika A, Reddy BS and Entingh AJ (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262
12. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188
13. Giardiello FM (1994) Sulindac and polyp regression. Cancer Metastasis Rev 13: 279-283
14. Giovannucci E, Egan KM, Hunter DJ, Slampfer MJ, Colditz GA, Willett WC and Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
15. Greenberg ER, Baron JA, Freeman Jr DH, Madel JS and Haile R (1993) Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst 85: 912-916
16. Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR and Dove WF (1996) Chemoprevention of spontaneous intestinal adenomas in the Apc mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 56: 710-714
17. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559
18. Lecomte M, Laneuville O, Ji C, Dewitt DL and Smith WL (1994) Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 269: 13207-13215
19. Lee M, Cryer B and Feldman M (1994) Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Med 120: 184-189
20. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
21. Meade EA, Smith WL and Dewitt DL (1993) Differential inhibition of prostagladin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614
22. Morin PJ, Vogelstein B and Kinzler KW (1996) Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-7954
23. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Takelo MM (1996) Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809
24. Pence BC, Dunn DM, Zhao C, Landers M and Wargovich MJ (1995) Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted carcinogenesis: correlation with intermediate endpoints. Carcinogenesis 16: 757-765
25. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS and Pamukcu R (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110-3116
26. Rao CV, Rivenson A, Simi B, Zange E, Kelloff G, Steele V and Reddy BS (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal antiinflammatory agent. Cancer Res 55: 1464-1472
27. Reddy BS, Rao CV, Rivenson A and Kelloff G (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493-1497
28. Reddy BS, Rao CV and Seibert K (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566-4569
29. Sunter JP, Appleton DR, Wright NA and Watson AJ (1978) Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Archiv B, Cell Pathol 29: 211-223
30. Thun MJ (1996) NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 25: 333-348
31. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp ORD and Dubois RN (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111: 1134-1340
32. Williams CS, Smalley W and Dubois RN (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100: 1325-1329